PCORI’s Slow Start On Comparative Research May Protect It From Political Heat
The Patient-Centered Outcomes Research Institute’s slow ramp-up to being in a position to fund comparative research projects may actually help it survive a heated political environment in an election year.
You may also be interested in...
During the run-up to the passing of the Affordable Care Act, the Patient-Centered Outcomes Research Institute was the target of much Republican criticism. But based on her interactions with congressional members, Project HOPE’s Gail Wilensky says there’s no desire now on Capitol Hill to end the institute’s activities.
Lack Of Cost-Effectiveness Analysis For Products In Development Could Affect Company Valuations, Attorney Mahinka Says
With payers playing a more prominent role in determining access to drugs, developers will need to focus more on the comparative value of a drug throughout the development cycle, including cost. That value equation also will become an important part of the M&A landscape, attorney Stephen Mahinka says.
The first version of the framework consists of a list of features that research projects ultimately selected for funding will include, but no specific agenda items were offered. Cmte. also updates national priorities.